Granisetron
Long-acting anti-sickness medicine for chemotherapy and surgery.
- Starts working
- 30–60 minutes
- Half-life
- About 9 hours
- In use since
- —
- Pregnancy
- Use with caution
Overview
Granisetron blocks 5-HT3 receptors in the gut and brain. It is used to prevent nausea and vomiting after chemotherapy, radiotherapy and surgery, and is available as a skin patch.
Conditions it's used for
How it works
Blocks serotonin signals that trigger vomiting.
Granisetron belongs to the 5-HT3 antagonists. How 5-HT3 antagonists work: block serotonin signals from the gut and brain's vomiting centre.
Uses
- Chemotherapy-induced nausea and vomiting
- Postoperative nausea and vomiting
- Radiotherapy-induced nausea
Available as: tablet, iv injection, transdermal patch.
Typical dose
- Adults
- 1 mg twice a day or 2 mg once a day by mouth; 1 mg IV before chemotherapy.
- Children
- 10 micrograms/kg IV.
Typical doses for orientation only. Your prescription, the pack leaflet and local guidance take priority.
Side effects
Common
Often mild and may settle with time
- Headache
- Constipation
- Tiredness
- Dizziness
Serious — get medical help
Uncommon, but need prompt attention
- QT prolongation
- Serotonin syndrome (rare)
- Allergic reactions
Warnings
- Avoid with other QT-prolonging drugs where possible
Who should avoid it
- Known QT prolongation
- Taking apomorphine
Interactions
- QT-prolonging drugs — rhythm risk
- Serotonergic drugs — serotonin syndrome (rare)
- Apomorphine — contraindicated
Other medicines in the atlas that need care with Granisetron, grouped by the reason:
High risk of dangerous heart rhythmMajorWith Amiodarone, Methadone
Both medicines prolong the QT interval; with a strongly QT-prolonging drug, torsades de pointes becomes a real risk.
What's usually done: Avoid where possible. If combined, check an ECG and keep potassium and magnesium normal.
Additive QT prolongationModerateWith Amisulpride, Amitriptyline, Artemether–lumefantrine, Azithromycin, Bedaquiline and 35 more
Both medicines can lengthen the QT interval. The risk is higher with heart disease, low potassium or magnesium, older age and female sex.
What's usually done: Often acceptable in people without risk factors; an ECG may be advised. Report palpitations or fainting.
Higher rhythm riskModerateWith Clarithromycin, Darunavir, Erythromycin, Itraconazole, Lopinavir-ritonavir and 2 more
Some CYP3A4 inhibitors raise concentrations of QT-prolonging medicines, adding to the risk of torsades and fainting.
What's usually done: Avoid high-risk combinations where possible; review the specific medicine and consider ECG monitoring.
Using it safely
- Alcohol
- Usually no problem in moderation. No specific interaction.
- Food and drink
- With or without food.
- If you miss a dose
- Take when remembered; skip if near the next dose.
- Stopping it
- Used for short periods.
- Driving
- Usually no effect.
- Tests and checks
- ECG in risk groups
- If too much is taken
- Headache and constipation; seek advice.
- Storage
- Room temperature.
- Legal status
- United States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM)India: Schedule HAustralia: Prescription only (Schedule 4)
Pregnancy and breastfeeding
Pregnancy
Use with caution
Limited data.
Breastfeeding
Use with caution
Limited data.
Special groups
- Kidney disease
- No adjustment.
- Liver disease
- No adjustment.
- Older adults
- Standard dosing.
Brand names
- United States
- Sustol, Kytril
- United Kingdom
- Kytril, Sancuso
- India
- Kytril, Granicip, Granisetron (generic)
- Australia
- Kytril
Examples only; many generic versions exist. The same brand name can mean different products in different countries.
Common questions
Do I need a prescription for Granisetron?
Yes — Granisetron is prescription-only in most countries.
Can I take Granisetron during pregnancy?
Use with caution. Limited data. Always check with a doctor or midwife.
How quickly does Granisetron work?
30–60 minutes.
Related medicines
Sources and official information
- MedlinePlus (US National Library of Medicine)
- DailyMed — official US labels
- NHS medicines A–Z
- WHO ATC/DDD index — A04AA02
Entry last reviewed October 2026. Compiled from WHO, NHS, FDA/DailyMed, BNF and national formulary information. How we write entries.